Therapeutic Advances in Drug Safety

Papers
(The H4-Index of Therapeutic Advances in Drug Safety is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Survival outcomes of beta-blocker usage in HER2-positive advanced breast cancer patients: a retrospective cohort study51
Association between number of medications and indicators of potentially inappropriate polypharmacy: a population-based cohort of older adults in Quebec, Canada48
Development and psychometric assessment of self-reported patient medication safety scale (SR-PMSS)31
Medication errors by caregivers in the homes of children discharged from a pediatric department in Ghana31
Semaglutide: a gendered phenomenon—women’s increased vulnerability to adverse drug reactions in the global weight loss trend19
Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community19
Enhancing pharmacovigilance for robust drug safety monitoring: addressing underreporting and collaborative solutions17
Adverse events of topical ocular prostaglandin medications for glaucoma treatment: a pharmacovigilance study based on the FAERS database16
Acceptability of a cross-sectoral hospital pharmacist intervention for patients in transition between hospital and general practice: a mixed methods study16
A critical opinion-based review of hospital pharmacy compounding with respect to the risk of leachable substances due to the off-label use of plastic primary packaging16
Factors related to dosing frequency and route of administration in methotrexate intolerance among patients with rheumatoid arthritis: a cross-sectional study16
Understanding, readiness, and response of healthcare professionals in combating falsified medical products in Eritrea: a population-based survey15
Corrigendum15
Implementation of electronic distribution of Direct Healthcare Professional Communications by the Danish Medicines Agency: a survey study of physicians’ experiences and preferences13
Incidence of antibody–drug conjugate-related hepatotoxicity in breast cancer: a systematic review and meta-analysis13
0.56897902488708